Chemotherapy Research - Cancer treatment, Side effects, drugs

Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.


Chemotherapy Research Today

Home

View Latest Issue

Information About Chemotherapy

Books on Chemotherapy

Advertising in Research Today

View Other Research Today Publications



Volume 1 (2004), Issue 1 (November)

  1. Lack of association between dyslipidemia and insulin resistance in HIV-infected persons treated with highly active antiretroviral therapy.
    Nutrition, 20(11): 1022-5. [Abstract] [Full-text]
  2. Bacterial ghosts--biological particles as delivery systems for antigens, nucleic acids and drugs.
    Curr Opin Biotechnol, 15(6): 530-7. [Abstract] [Full-text]
  3. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs.
    Curr Opin Biotechnol, 15(6): 518-29. [Abstract] [Full-text]
  4. Virus-like particles as vaccines and vessels for the delivery of small molecules.
    Curr Opin Biotechnol, 15(6): 513-7. [Abstract] [Full-text]
  5. Exploiting receptor biology for oral vaccination with biodegradable particulates.
    Adv Drug Deliv Rev, 57(3): 431-50. [Abstract] [Full-text]
  6. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
    Adv Drug Deliv Rev, 57(3): 411-30. [Abstract] [Full-text]
  7. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.
    Adv Drug Deliv Rev, 57(3): 391-410. [Abstract] [Full-text]
  8. DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells.
    Adv Drug Deliv Rev, 57(3): 377-90. [Abstract] [Full-text]
  9. Formulation aspects of biodegradable polymeric microspheres for antigen delivery.
    Adv Drug Deliv Rev, 57(3): 357-76. [Abstract] [Full-text]
  10. Immunity in response to particulate antigen-delivery systems.
    Adv Drug Deliv Rev, 57(3): 333-55. [Abstract] [Full-text]
  11. In vitro studies on controlled-release cellulose acetate films for local delivery of chlorhexidine, indomethacin, and meloxicam.
    J Clin Periodontol, 31(12): 1117-21. [Abstract] [Full-text]
  12. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Klin Padiatr, 216(6): 331-42. [Abstract] [Full-text]
  13. Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme.
    J Cancer Res Clin Oncol, 131(1): 31-40. [Abstract] [Full-text]
  14. Audit of antibiotic use in a Brazilian University Hospital.
    Braz J Infect Dis, 8(4): 272-80. [Abstract] [Full-text]
  15. Antibiotics on urethral catheter withdrawal: a hit and miss affair.
    J Hosp Infect, 58(4): 297-302. [Abstract] [Full-text]
  16. Effects of drugs on olfaction and taste.
    Otolaryngol Clin North Am, 37(6): 1229-54. [Abstract] [Full-text]
  17. Olfactory loss as a result of toxic exposure.
    Otolaryngol Clin North Am, 37(6): 1185-207. [Abstract] [Full-text]
  18. Estrogen and combined estrogen-progestogen therapy in the menopause and breast cancer.
    Breast, 13(6): 515-8. [Abstract] [Full-text]
  19. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation.
    J Pharm Pharmacol, 56(12): 1509-17. [Abstract] [Full-text]
  20. Targeting beta-cell cyclic 3'5' adenosine monophosphate for the development of novel drugs for treating type 2 diabetes mellitus. A review.
    J Pharm Pharmacol, 56(12): 1477-92. [Abstract] [Full-text]
  21. Influence of EDA-pi interactions in drug encapsulation using nanospheres.
    Chem Commun (Camb). [Abstract] [Full-text]
  22. Derivative weighted active insulin control modelling and clinical trials for ICU patients.
    Med Eng Phys, 26(10): 855-66. [Abstract] [Full-text]
  23. An interview strategy was critical for obtaining valid information on the use of hormone replacement therapy.
    J Clin Epidemiol, 57(11): 1210-3. [Abstract] [Full-text]
  24. Modified polyethylenimines as non-viral gene delivery systems for aerosol gene therapy: investigations of the complex structure and stability during air-jet and ultrasonic nebulization.
    J Control Release, 100(3): 437-50. [Abstract] [Full-text]
  25. Modified polyethylenimines as non viral gene delivery systems for aerosol therapy: effects of nebulization on cellular uptake and transfection efficiency.
    J Control Release, 100(3): 425-36. [Abstract] [Full-text]
  26. Comparison of antisense oligonucleotide drug delivery systems.
    J Control Release, 100(3): 411-23. [Abstract] [Full-text]
  27. Conjugation of an antibody to cross-linked fibrin for targeted delivery of anti-restenotic drugs.
    J Control Release, 100(3): 357-77. [Abstract] [Full-text]
  28. Novel neuronal targets for the acetylcholinesterase inhibitor donepezil.
    Neuropharmacology, 47(8): 1198-204. [Abstract] [Full-text]
  29. The interaction between carrier rugosity and carrier payload, and its effect on drug particle redispersion from adhesive mixtures during inhalation.
    Eur J Pharm Biopharm, 59(1): 197-205. [Abstract] [Full-text]
  30. Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation.
    Eur J Pharm Biopharm, 59(1): 177-87. [Abstract] [Full-text]
  31. Synthesis and properties of polysaccharide prodrugs of 5-aminosalicylic acid as potential colon-specific delivery systems.
    Eur J Pharm Biopharm, 59(1): 155-60. [Abstract] [Full-text]
  32. Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid.
    Eur J Pharm Biopharm, 59(1): 85-97. [Abstract] [Full-text]
  33. Applying pattern recognition methods and structure property correlations to determine drug carrier potential of nicotinic acid and analogize to dihydropyridine.
    Eur J Pharm Biopharm, 59(1): 63-71. [Abstract] [Full-text]
  34. Non-phospholipid vesicles for pulmonary glucocorticoid delivery.
    Eur J Pharm Biopharm, 59(1): 57-62. [Abstract] [Full-text]
  35. S-nitrosoglutathione incorporated in poly(ethylene glycol) matrix: potential use for topical nitric oxide delivery.
    Nitric Oxide, 11(3): 263-72. [Abstract] [Full-text]
  36. Effects of hormone replacement therapy or raloxifene on ambulatory blood pressure and arterial stiffness in treated hypertensive postmenopausal women.
    Am J Cardiol, 94(11): 1453-6. [Abstract] [Full-text]
  37. Impact of fluid balance on incidence of atrial fibrillation after cardiothoracic surgery.
    Am J Cardiol, 94(11): 1423-5. [Abstract] [Full-text]
  38. Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration.
    Liver Int, 24(6): 540-6. [Abstract] [Full-text]
  39. Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance.
    J Gen Intern Med, 19(11): 1104-10. [Abstract] [Full-text]
  40. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
    Br J Haematol, 127(5): 543-51. [Abstract] [Full-text]
  41. Medication errors in pediatrics--the octopus evading defeat.
    J Surg Oncol, 88(3): 182-8. [Abstract] [Full-text]
  42. Erythrocytes-the 'house elves' of photodynamic therapy.
    Photochem Photobiol Sci, 3(11): 981-9. [Abstract] [Full-text]
  43. Surgical thrombectomy followed by intraoperative endovascular reconstruction for symptomatic ilio-femoral venous thrombosis.
    Eur J Vasc Endovasc Surg, 29(1): 58-66. [Abstract] [Full-text]
  44. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
    J Clin Oncol, 22(23): 4787-94. [Abstract] [Full-text]
  45. Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
    J Clin Oncol, 22(23): 4779-86. [Abstract] [Full-text]
  46. Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.
    J Clin Oncol, 22(23): 4762-71. [Abstract] [Full-text]
  47. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
    J Clin Oncol, 22(23): 4753-61. [Abstract] [Full-text]
  48. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
    J Clin Oncol, 22(23): 4691-9. [Abstract] [Full-text]
  49. Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196.
    J Clin Oncol, 22(23): 4683-90. [Abstract] [Full-text]
  50. Vector targeting makes 5-fluorouracil chemotherapy less toxic and more effective in animal models of epithelial neoplasms.
    Clin Cancer Res, 10(22): 7738-46. [Abstract] [Full-text]
  51. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy.
    Clin Cancer Res, 10(22): 7677-84. [Abstract] [Full-text]
  52. Sensitization of tumor-associated endothelial cell apoptosis by the novel vascular-targeting agent ZD6126 in combination with cisplatin.
    Clin Cancer Res, 10(22): 7671-6. [Abstract] [Full-text]
  53. Recurrent ovarian cancer: how important is it to treat to disease progression?
    Clin Cancer Res, 10(22): 7439-49. [Abstract] [Full-text]
  54. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
    Aliment Pharmacol Ther, 20(10): 1125-31. [Abstract] [Full-text]
  55. An update on the neuropathology of HIV in the HAART era.
    Histopathology, 45(6): 549-59. [Abstract] [Full-text]
  56. Targeting DNA with novel diphenylcarbazoles.
    Biochemistry, 43(48): 15169-78. [Abstract] [Full-text]
  57. Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen.
    Hepatology, 40(6): 1361-9. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Chemotherapy Research Today. All Rights Reserved.



Chemotherapy Research Today Archive:

Volume 1 (2004)
  Issue 1 (November)
  Issue 2 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)



Chemotherapy Books

Chemotherapy and Radiation For Dummies

Chemotherapy and Radiation For Dummies